论文部分内容阅读
2月27日,利尔化学股份有限公司发布董事会公告,决定自筹资金9,800万元在绵阳基地现有厂区内对现有草铵膦原药生产线及配套设施进行技改扩能,项目预计于2016年9月底完成安装调试并投入运行。公告称,项目达产后,利尔化学绵阳基地的草铵膦原药生产能力将达到5000吨/年,预计将新增年均销售收入约3.38亿元,新增年均税后净利润约0.67亿元。利尔表示,上述草膦原药扩产项目符合公
February 27, Lear Chemical Co., Ltd. announced the Board of Directors, decided to self-financed 98 million yuan in the existing plant in Mianyang base of the existing production line of glufosinate original drugs and supporting facilities for technological transformation and expansion, the project is expected to By the end of September 2016 to complete the installation and commissioning and put into operation. The announcement said that after the completion of the project, Lear Chemical Mianyang base of glufosinate production capacity will reach 5,000 tons / year is expected to add annual sales revenue of about 338 million yuan, net profit after the new average annual profit of about 0.67 100 million yuan. Li Er said that the above Phosphorus Propolis drug expansion project in line with the public